In patients with early rheumatoid arthritis who had a remission while receiving full-dose etanercept-plus-methotrexate therapy , continuing combination therapy at a reduced dose resulted in better disease control than switching to methotrexate alone or placebo , but no significant difference was observed in radiographic progression .